(Q43818857)

27 November 2017

Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study (English)

1 reference

27 November 2017

1 reference

essential hypertension

1 reference

P Verdecchia

1

1 reference

27 November 2017

G Carini

2

1 reference

27 November 2017

A Circo

3

1 reference

27 November 2017

E Dovellini

4

1 reference

27 November 2017

E Giovannini

5

1 reference

27 November 2017

M Lombardo

6

1 reference

27 November 2017

P Solinas

7

1 reference

27 November 2017

M Gorini

8

1 reference

27 November 2017

A P Maggioni

9

1 reference

27 November 2017

MAVI (MAssa Ventricolare sinistra nell'Ipertensione) Study Group

10

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Journal of the American College of Cardiology

27 November 2017

1 reference

27 November 2017

38

1 reference

27 November 2017

1829-1835

1 reference

27 November 2017

7

1 reference

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Prognostic significance of serial changes in left ventricular mass in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Impact of left ventricular hypertrophy on survival in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

The clinical course of left ventricular hypertrophy in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Improved electrocardiographic diagnosis of left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Identification of risk factors in hypertensive patients: contribution of randomized controlled trials through an individual patient database

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Left Ventricular Mass and Risk of Stroke in an Elderly Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901663-1

7 January 2021

10.1016/S0735-1097(01)01663-1

Identifiers

DOI

1 reference

27 November 2017

1 reference